[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"apoptosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:apoptosis":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100527453","prognostic-role-of-inhibitor-of-apoptosis-protein-overexpression-on-recurrence-rate-in-cervical-cancer-100527453",false,"NCT06147960","Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer","Evaluation of the Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on the 24-month Recurrence Rate in Locally Advanced Cervical Cancer","EPIcol","Inclusion Criteria:\n\n* Patients treated with the exclusive radio-chemotherapy combination for locally advanced cervical carcinoma (stage Ib-IVb according to FIGO classification).\n* Patients aged ≥ 18 years.\n* Patients with a minimum of 2 years post-treatment follow-up.\n* Patients for whom the initial biopsy specimen (before treatment) is available.\n* Patients who have not indicated that they do not wish to participate in the study.\n* Patients affiliated to or benefiting from a health insurance scheme.\n\nExclusion Criteria:\n\n* Patients under court protection, guardianship or curatorship.","FEMALE","18 Years",{"count":20,"type":21},180,"ESTIMATED","OBSERVATIONAL","Overexpression of inhibitors of apoptosis proteins (IAPs) in patients treated for locally advanced cervical cancer with exclusive radio-chemotherapy may have a prognostic role on the local recurrence rate at 24 months.",[25,26],"Cancer of Cervix","Apoptosis",[28,29,26],"Apoptosis inhibiting proteins","Cervical cancer","RECRUITING","2026-06-18",{"date":33,"type":34},"2026-06-22","ACTUAL",{"date":36,"type":34},"2024-09-26",{"date":38,"type":21},"2027-11",{"name":40,"class":41},"Centre Hospitalier Universitaire de Nīmes","OTHER"]